Management Team

Prof. Hartmut J. Ehrlich, M.D. Chief Executive Officer
Didier Blondel EVP, Chief Financial Officer & Board Secretary
Sheldon Sloan, M.D., M. Bioethics Chief Medical Officer
Pierre Courteille, Pharmacist, MBA Chief Commercial Officer & Vice President of Business Development
Paul Gineste, Pharm D. Vice President of Clinical Operations
Mary Mantock, MSc Vice President Regulatory Affairs
Jérôme Denis, Ph.D. Vice President Process Development & Manufacturing
Sylvie Girardet Quality Director
Bob Clay, MSc, MBA Development Strategy Adviser
Didier Scherrer, Ph.D. Vice President of R&D
Prof. Jamal Tazi, Ph.D. Vice President Research
Regina Jehle Vice President Communications

Board of Directors

Corinna zur Bonsen-Thomas Chairman of the Board of Abivax; Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
Philippe Pouletty, M.D. Founder of Abivax; Managing Partner of Truffle Capital
Joy Amundson Former President of Baxter BioScience; Former member of the Board of Directors of Covidien
Kinam Hong, M.D., MBA, CFA Partner at the Crossover Fund Sofinnova
Jean-Jacques Bertrand Former Chairman of the Board of Directors of Pierre Fabre; Former CEO of Aventis Pasteur; Former Chairman of LEEM
Antonino Ligresti, M.D. Former President of Générale de Santé; Member of the Board of Directors at CARMAT
Prof. Carol Brosgart, M.D. Clinical Professor of Medicine, Epidemiology and Biostatistics at the University of California; Senior Advisor on Science and Policy, VHAC at the CDC Foundation and the Division of Viral Hepatitis at CDC; Former VP Clinical Research of Gilead Sciences
Christian Pierret Senior Counsel at August Debouzy; Former French Minister of Industry

Scientific Advisory Board

Prof. Ian McGowan, M.D., Ph.D., Chairman Adjunct Professor, University of Pittsburgh, U.S.; Chief Medical Officer, Orion Biotechnology, Ottawa, Canada; Former Chairman of the U.S. FDA Antiviral Drugs Advisory Committee, U.S.
Prof. Christian Bréchot, M.D., Ph.D Assistant VP and Professor, College of Medicine Internal Medicine at the University of South Florida, Tampa, Florida, U.S.; Former Head of the Institut Pasteur, Paris, France; Former General Director at INSERM, Paris, France
Prof. Christoph Huber, M.D. Former Chairman of the Department of Hematology-Oncology, University Medical Center of Mainz, Germany; Co-Founder and Board Member of BioNTech, Mainz, Germany
Prof. Jürgen Rockstroh, M.D. Professor of Medicine and Head of the Outpatient Clinic for Infectiology & Immunology, University Hospital of Bonn, Germany; President of the European AIDS Clinical Society (EACS)
Prof. Lawrence R. Stanberry, M.D., Ph.D Associate Dean for International Programs, Columbia University Vagelos College of Physicians and Surgeons, New York, U.S.; Former Chairman of the Department of Pediatrics at the Columbia University, New York, U.S.
Prof. Christian Trépo, M.D., Ph.D. Department of Hepato-Gastroenterology, University Hospital Center Lyon, France; Former Head of the Hepatitis Research Unit at INSERM, Lyon, France
Prof. Luc Teyton, M.D., Ph.D. Professor at the Department of Immunology and Microbiology, Scripps Research Center, California Campus, U.S.
Claude Bertrand, Pharm.D, Ph.D. Executive Vice-President R&D and Chief Scientific Officer of Servier, Suresnes, France